相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association Between Prehospital Vitamin D Status and Hospital-Acquired Clostridium difficile Infections
Sadeq A. Quraishi et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2015)
Vitamin D Status and Severity of Clostridium difficile Infections: A Prospective Cohort Study in Hospitalized Adults
Gwendolyn M. van der Wilden et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2015)
Association Between Reduced Plasma 25-Hydroxy Vitamin D and Increased Risk of Cancer in Patients With Inflammatory Bowel Diseases
Ashwin N. Ananthakrishnan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile-associated diarrhea
Wallace J. Wang et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2014)
Genetic risk factors for Clostridium difficile infection in ulcerative colitis
A. N. Ananthakrishnan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice
Tressia C. Hing et al.
GUT (2013)
Improving Case Definition of Crohn's Disease and Ulcerative Colitis in Electronic Medical Records Using Natural Language Processing: A Novel Informatics Approach
Ashwin N. Ananthakrishnan et al.
INFLAMMATORY BOWEL DISEASES (2013)
Do statins protect against the development of Clostridium difficile-associated diarrhoea?
William Nseir et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis
S. K. Murthy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Review article: vitamin D and inflammatory bowel disease - established concepts and future directions
M. Garg et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease
A. N. Ananthakrishnan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
A comprehensive summary of LL-37, the factotum human cathelicidin peptide
Dieter Vandamme et al.
CELLULAR IMMUNOLOGY (2012)
Higher Predicted Vitamin D Status Is Associated With Reduced Risk of Crohn's Disease
Ashwin N. Ananthakrishnan et al.
GASTROENTEROLOGY (2012)
Statin use and the risk of Clostridium difficile in academic medical centres
Christine Anne Motzkus-Feagans et al.
GUT (2012)
Management of inflammatory bowel disease with vitamin D: Beyond bone health
Neeraj Narula et al.
JOURNAL OF CROHNS & COLITIS (2012)
Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease
M-H. Jen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency
Gerry K. Schwalfenberg
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Clostridium difficile infection: epidemiology, risk factors and management
Ashwin N. Ananthakrishnan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Improving Surveillance for Pediatric Clostridium difficile Infection Derivation and Validation of an Accurate Case-finding Tool
Julia Shaklee et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Clinical Outcomes of Patients with Ulcerative Colitis and Co-existing Clostridium difficile Infection
Daniela Jodorkovsky et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Healthcare costs of Staphylococcus aureus and Clostridium difficile infections in Veterans: role of vitamin D deficiency
D. Youssef et al.
EPIDEMIOLOGY AND INFECTION (2010)
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections
S. Schneeweiss et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Low Plasma Level of Cathelicidin Antimicrobial Peptide (hCAP18) Predicts Increased Infectious Disease Mortality in Patients Undergoing Hemodialysis
Adrian F. Gombart et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clostridium Difficile and Inflammatory Bowel Disease
Ashwin N. Ananthakrishnan et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2009)
Use of International Classification of Diseases, Ninth Revision, Clinical Modification Codes and Medication Use Data to Identify Nosocomial Clostridium difficile Infection
Mia Schmiedeskamp et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
cAMP Stringently Regulates Human Cathelicidin Antimicrobial Peptide Expression in the Mucosal Epithelial Cells by Activating cAMP-response Element-binding Protein, AP-1, and Inducible cAMP Early Repressor
Krishnendu Chakraborty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients
Geoffrey C. Nguyen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Human α-defensins inhibit Clostridium difficile toxin B
Torsten Giesemann et al.
GASTROENTEROLOGY (2008)
Administration of oral vitamin D induces cathelicidin production in atopic individuals
Tissa R. Hata et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease
A. N. Ananthakrishnan et al.
GUT (2008)
Impact of Clostridium difficile on inflammatory bowel disease
Mazen Issa et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
ICD-9 codes and surveillance for Clostridium difficile-associated disease
Erik R. Dubberke et al.
EMERGING INFECTIOUS DISEASES (2006)
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease
S Dial et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Mechanisms of disease: vitamin D and inflammatory bowel disease
WC Lim et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors:: cohort and case-control studies
S Dial et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
分享论文
